Tus-Pharmaceutical Group Co., Ltd.

Shenzhen Stock Exchange 000590.SZ

Tus-Pharmaceutical Group Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 3.80%

Tus-Pharmaceutical Group Co., Ltd. Return on Capital Employed (ROCE) is 3.80% for the year ending December 31, 2023, a 47.04% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Tus-Pharmaceutical Group Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 2.58%, a -52.46% change year over year.
Tus-Pharmaceutical Group Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 5.43%, a 43.05% change year over year.
Tus-Pharmaceutical Group Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 3.80%, a -52.59% change year over year.
Tus-Pharmaceutical Group Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 8.01%, a 265.31% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

Shenzhen Stock Exchange: 000590.SZ

Tus-Pharmaceutical Group Co., Ltd.

CEO	Ms. Ting Tang
IPO Date	Jan. 19, 1996
Location	China
Headquarters	No. 33, Yangliu Road
Employees	1,237
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Consumer Packaged Goods Cosmetics Drugstores & Retail Pharmacies Personal Care Tobacco

Description

Tus-Pharmaceutical Group Co., Ltd. manufactures and sells traditional Chinese medicine and western medicine products. The company was formerly known as Tus-Guhan Group Corp.,Ltd. Tus-Pharmaceutical Group Co., Ltd. was founded in 1956 and is based in Hengyang, China.

Key trends

Past 5 years